Description
Dengue virus (DV) infections cause undisputedly the most important arthropod-borne viral disease in terms of worldwide prevalence, human suffering, and cost. Worldwide DV infection prevalence in 2010 was between 284 to 528 million cases. Approximately 84% of these cases come from Asia and the Americas, where the cost for emerging economies can be as high as 580 million dollars per year.
Copyright Statement
Reuse Permissions
Download count: 0
Details
Contributors
- Maria del Angel, Rosa (Author)
- Reyes del Valle, Jorge (Author)
- College of Liberal Arts and Sciences (Contributor)
Date Created
The date the item was original created (prior to any relationship with the ASU Digital Repositories.)
2013-10-03
Resource Type
Collections this item is in
Identifier
- Digital object identifier: 10.1371/journal.ppat.1003551
- Identifier TypeInternational standard serial numberIdentifier Value1553-7366
- Identifier TypeInternational standard serial numberIdentifier Value1553-7374
Note
- The article is published at http://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1003551, opens in a new window
Citation and reuse
Cite this item
This is a suggested citation. Consult the appropriate style guide for specific citation guidelines.
Angel, R. M., & Valle, J. R. (2013). Dengue Vaccines: Strongly Sought but Not a Reality Just Yet. PLoS Pathogens, 9(10). doi:10.1371/journal.ppat.1003551